Alzheimer Disease Treatment Drugs Markets in China

TABLE OF CONTENTS

I.INTRODUCTION

Report Scope and Methodology

Executive Summary

II.BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators

Industrial Output

Population and Labor

Foreign Investment

Foreign Trade

Financial and Tax Regulations

Banking System and Regulations

Foreign Exchange

Taxes, Tariff and Custom Duties

III.ALZHEIMER’S DISEASE DRUGS INDUSTRY ASSESSMENTS

Alzheimer Disease Drugs Industry Structure

Market Size

Market Growth Drivers

Alzheimer’s Disease Drugs Sales Volume

Major Producer Facility Locations and Sales Volume

Market Share of Key Producers

Labor Cost

Potential Entrants

Major Distributors

Major Foreign Investments

Technology Development

IV.ALZHEIMER’S DISEASE DRUGS PRODUCTION AND DEMAND

Overview

Demand of Alzheimer’s Disease Drugs by Region

Alzheimer’s Disease Drugs Sales Volume

Ginkgo Bilota Extract

Breviscapine

Ganglioside

Donepezil

Galanthamine

Nicergoline

Rivastigmine

Memantine

Huperzine A

Oxiracetam

Flunarizine

Piracetam

Other Alzheimer’s Disease Drugs

Alzheimer’s Disease Drugs Imports

Ginkgo Bilota Extract Imports

Breviscapine Imports

Ganglioside Imports

Donepezil Imports

Galanthamine Imports

Nicergoline Imports

Rivastigmine Imports

Memantine Imports

Huperzine A Imports

Oxiracetam Imports

Flunarizine Imports

Piracetam Imports

Other Alzheimer’s Disease Drugs Imports

Pricing Trend

V. ALZHEIMER’S DISEASE DRUGS MARKET OUTLOOK

Alzheimer’s Disease Drugs Markets Outlook Overview

Government Regulations

Health Care Insurance Industry Overview

Consumer Spending Trends By Region

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview

China’s Distribution System

Alzheimer’s Disease Drugs Distribution Channels

Transportation and Freight Infrastructure

Communications

China’s Market Entry

Export to China

Indirect Export

Direct Export

License and Contract Manufacture

Assembling in China

Contract Manufacturing

Trade Permit

Investment

Equity Joint Venture

Contractual Joint Venture

Wholly Foreign-Owned Enterprise

VII. ALZHEIMER’S DISEASE DRUGS PRODUCER DIRECTORY

Major Alzheimer’s Disease Drugs Producer Profiles

Distributors and Trading Companies

Associations and Research Institutes

Major End-Users

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators

Industrial Output

Population and Labor Force Trends

Foreign Investment and Loans

Foreign Trade

III.ALZHEIMER’S DISEASE DRUGS INDUSTRY ASSESSMENTS

Alzheimer’s Disease Drugs Sales Volume

Major Producer Facility Locations

Major Alzheimer’s Disease Drugs Producer Sales Volume

Market Share of Key Producers

Major Foreign Investments

IV.ALZHEIMER’S DISEASE DRUGS PRODUCTION AND DEMAND

Total Alzheimer’s Disease Drugs Sales Volume

Alzheimer’s Disease Drugs Major Producer and Their Market Share

Ginkgo Bilota Extract Major Producer and Their Market Share

Breviscapine Major Producer and Their Market Share

Ganglioside Major Producer and Their Market Share

Donepezil Major Producer and Their Market Share

Galanthamine Major Producer and Their Market Share

Dihydroergotamine Major Producer and Their Market Share

Rivastigmine Major Producer and Their Market Share

Memantine Major Producer and Their Market Share

Huperzine A Major Producer and Their Market Share

Oxiracetam Major Producer and Their Market Share

Flunarizine Major Producer and Their Market Share

Piracetam Major Producer and Their Market Share

Alzheimer’s Disease Drugs Import

V. ALZHEIMER’S DISEASE DRUGS MARKET OUTLOOK

Consumer Spending Trend

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits

LIST OF CHARTS

I. NTRODUCTION

Alzheimer’s Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China’s GDP and Industrial Output

Industrial Output by Ownership

China’s Imports and Exports

III.ALZHEIMER’S DISEASE DRUGS INDUSTRY ASSESSMENTS

Alzheimer’s Disease Drugs Sales Volume

II. ALZHEIMER’S DISEASE DRUGS PRODUCTION AND

DEMAND

Alzheimer’s Disease Drugs Sales Volume

Worldwide Alzheimer’s Disease Drugs Demand by Region

Ginkgo Bilota Extract Sales Volume and Market Share

Breviscapine Sales Volume and Market Share

Ganglioside Sales Volume and Market Share

Donepezil Sales Volume and Market Share

Galanthamine Sales Volume and Market Share

Dihydroergotamine Sales Volume and Market Share

Rivastigmine Sales Volume and Market Share

Memantine Sales Volume and Market Share

Huperzine A Sales Volume and Market Share

Oxiracetam Sales Volume and Market Share

Flunarizine Sales Volume and Market Share

Piracetam Sales Volume and Market Share

Other Alzheimer’s Disease Drugs Sales volume and market share

Alzheimer’s Disease Drugs Import Volume

Ginkgo Bilota Extract Import Volume and Market Share

Breviscapine Import Volume and Market Share

Ganglioside Import Volume and Market Share

Donepezil Import Volume and Market Share

Galanthamine Import Volume and Market Share

Dihydroergotamine Import Volume and Market Share

Rivastigmine Import Volume and Market Share

Memantine Import Volume and Market Share

Huperzine A Import Volume and Market Share

Oxiracetam Import Volume and Market Share

Flunarizine Import Volume and Market Share

Piracetam Import Volume and Market Share

Other Alzheimer’s Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

China’s Distribution Channel

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.